Merrimack Pharmaceuticals

Listing Websites about Merrimack Pharmaceuticals

Filter Type:

Merrimack Pharmaceuticals

(6 days ago) Merrimack Pharmaceuticals. Merrimack Pharmaceuticals, Inc. (the “Company”) is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. (“Ipsen”) in April 2017. The Company does not have any ongoing research or development

Merrimack.com

Category:  Pharmaceutical Detail Drugs


Merrimack to Lay Off Remaining Execs and Staff, Sell

(1 days ago) Merrimack Pharmaceuticals will lay off its entire staff, including its leadership team, as the Cambridge, Mass.-based company looks to be in the midst of shutting down.. On Thursday, the company announced the results of a months-long strategic review that include the job cuts, as well as a deal with startup 14ner Oncology, Inc. Merrimack will sell its anti-Her3 monoclonal antibody …

Biospace.com

Category:  Pharmaceutical Detail Drugs


Ipsen to Acquire Oncology Assets from Merrimack

(1 days ago) Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals. Transaction includes U.S. commercialization rights for ONIVYDE® for metastatic pancreatic cancer in adult patients [1] $575 million cash at closing and additional potential payments for new indications. Transaction bolsters Ipsen’s growing oncology presence and leverages

Ipsen.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Price, News

(6 days ago) Merrimack Pharmaceuticals, Inc. Analyst Report: Gilead Sciences, Inc. Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


A Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) …

(7 days ago) The Last 12 Months Of Insider Transactions At Merrimack Pharmaceuticals. Over the last year, we can see that the biggest insider purchase was by President Gary Crocker for US$55k worth of …

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Max Dobles - Research Scientist - Charles River

(8 days ago) Merrimack Pharmaceuticals, Cambridge MA Jan 2009 - Dec 2012 4 years. Cambridge, MA Scientist Keel Pharmaceuticals, Inc. Jan 2006 - Sep 2008 2 years 9 months

Linkedin.com

Category:  Pharmaceutical Detail Drugs


MACK Stock Price Merrimack Pharmaceuticals Inc. Stock

(8 days ago) Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Message …

(2 days ago) Welcome to Merrimack Pharmaceuticals, Inc. (MACK) Board!!! At Merrimack, researchers, clinicians, professionals, and, yes, engineers work together in a multidisciplinary, team-based environment. All are committed to a single vision. Building cures for cancer. Our Leadership

Investorshub.advfn.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Ryan Overland - Seattle, Washington, United States

(9 days ago) Merrimack Pharmaceuticals. University of Washington. Report this profile About Experienced Associate Scientist in molecular biology and small animal research. Specialties: Animal handling

Linkedin.com

Category:  Pharmaceutical Detail Drugs


Karen Campbell - Senior Director Clinical Operations

(Just Now) Merrimack Pharmaceuticals Sep 2012 - Jun 2015 2 years 10 months. Cambridge, MA Clinical Research Manager Dana-Farber Cancer Institute Dec 2010 - Aug 2012 1 year 9 months. Outcome

Linkedin.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Divests Early Stage Asset for $2.25 Million

(3 days ago) Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent milestone payments related to its sale of ONIVYDE ® to Ipsen S.A. in April 2017 and up to $54.5 million in contingent milestone payments related to its sale of anti-HER3 programs to

Investors.merrimack.com

Category:  Pharmaceutical Detail Drugs


Kerri Carter - QC Senior Manager - Genzyme Corporation, a

(9 days ago) Senior QC Manager at Merrimack Pharmaceuticals Greater Boston. Grace Lee Senior Manager Process Development at Bio-Rad Laboratories San Ramon, CA. …

Linkedin.com

Category:  Pharmaceutical Detail Drugs


Working at Merrimack Pharmaceuticals: Employee Reviews

(Just Now) Work place culture. Senior Clinical Project Leader (Current Employee) - Cambridge, MA - November 20, 2017. Merrimack pharma is a very fast paced, innovative, patient centric culture. The company culture is exceptional, where all areas of the company collaborate, and interact. With a new scientific platform, exciting, and innovative company. Pros.

Indeed.com

Category:  Health Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Latest Stock News

(2 days ago) Merrimack Pharmaceuticals, Inc. Analyst Report: Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals discovers, develops, and commercializes …

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Investors Merrimack Pharmaceuticals

(2 days ago) CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov. 5, 2020-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its third quarter 2020 financial results for the period ended September 30, 2020 . “We are pleased that both Ipsen Pharmaceuticals and Elevation Oncology

Investors.merrimack.com

Category:  Pharmaceutical Detail Drugs


Merrimack Reports Second Quarter 2021 Financial Results

(2 days ago) Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent milestone payments related to its sale of ONIVYDE ® to Ipsen S.A. in April 2017.

Investors.merrimack.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. Common Stock (MACK) Stock

(Just Now) Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Press Releases Merrimack Pharmaceuticals

(6 days ago) CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Nov. 5, 2020-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its third quarter 2020 financial results for the period ended September 30, 2020 . “We are pleased that both Ipsen Pharmaceuticals and …

Investors.merrimack.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Historical

(4 days ago) Merrimack Pharmaceuticals, Inc. (MACK) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Add to watchlist. Visitors trend. 2W 10W 9M. 5.08 -0.02 (-0.39%)

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Working at Merrimack Pharmaceuticals Glassdoor

(3 days ago) Company - Public (MACK) Industry: Biotech & Pharmaceuticals. Revenue: $50 to $100 million (USD) Competitors: UNKNOWN. Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart

Glassdoor.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals Careers and Employment Indeed.com

(2 days ago) Find out what works well at Merrimack Pharmaceuticals from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Merrimack Pharmaceuticals is …

Indeed.com

Category:  Pharmaceutical Detail Drugs


Contact - Merrimack Pharmaceuticals

(4 days ago) Merrimack Pharmaceuticals, Inc. One Broadway, 14th floor Cambridge, MA 02142 617-720-8606. FOR ALL INQUIRIES [email protected]merrimack.com. MAILING ADDRESS One Broadway, 14th floor

Merrimack.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals FierceBiotech

(4 days ago) Merrimack Pharmaceuticals got an FDA approval for its cancer drug Onivyde in 2015. Then its CEO resigned in October 2016, and the company slashed 22% of …

Fiercebiotech.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack LinkedIn

(8 days ago) Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform

Linkedin.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals Announces Completion of

(1 days ago) CAMBRIDGE, Mass., May 30, 2019 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced the completion of its review of strategic alternatives, following which the Company's

Prnewswire.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals: Setting The Record Straight On

(4 days ago) Merrimack Pharmaceuticals: Setting The Record Straight On MM 398. May 16, 2014 12:01 PM ET Merrimack Pharmaceuticals, Inc. (MACK) 26 Comments. Decision Analytics. 764 Followers. Bio. Follow.

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Companies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Can

(3 days ago) Merrimack Pharmaceuticals' cash burn of US$4.3m is about 5.0% of its US$86m market capitalisation. That's a low proportion, so we figure the company would be …

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Latest News Merrimack Pharmaceuticals Stock ( MACK )

(2 days ago) 08:30pm, Thursday, 05'th Aug 2021 Merrimack Pharmaceuticals. CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 5, 2021-- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) (Merrimack or the Company) today announced its second quarter 2021 financial results for the period ended June 30, 2021 . We are pleased to report continued reductions in our operating

Stockinvest.us

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals - Crunchbase Company Profile

(5 days ago) Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal

Crunchbase.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals, Inc. - MACK - Stock Price Today

(2 days ago) Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for

Zacks.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Forum

(6 days ago) Find the latest Merrimack Pharmaceuticals, Inc. (MACK) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals - MACK - Stock Price & News

(9 days ago) Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for …

Fool.com

Category:  Pharmaceutical Detail Drugs


SEC Filings Merrimack Pharmaceuticals

(3 days ago) Merrimack Pharmaceuticals, Inc. One Broadway, 14th floor Cambridge, MA 02142 617-720-8606 [email protected]merrimack.com

Investors.merrimack.com

Category:  Pharmaceutical Detail Drugs


Working at Merrimack Pharmaceuticals: Employee Reviews

(2 days ago) Reviews from Merrimack Pharmaceuticals employees about Management. Management is tight, but the company values its employees. The company had too much on their plate trying to push 4+ drugs through FDA clinical trials simultaneously.

Indeed.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals Inc - AnnualReports.com

(7 days ago) Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.

Annualreports.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Partnering 2020 - Merrimack Pharmaceuticals

(4 days ago) For more info, please email: [email protected]merrimack.com . Author: Pamela Created Date: 1/7/2020 3:36:35 PM

Merrimack.com

Category:  Health Detail Drugs


MACK: Merrimack Pharmaceuticals Inc - Stock Price, Quote

(2 days ago) Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is entitled to receive contingent milestone payments related to its …

Cnbc.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (MACK) Stock Price Today

(6 days ago) A high-level overview of Merrimack Pharmaceuticals, Inc. (MACK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals (MACK) - Forbes

(9 days ago) Back on May 13, Merrimack Pharmaceuticals Inc.'s Director, Michael E. Porter, invested $97,668.36 into 8,284 shares of MACK, for a cost per share …

Forbes.com

Category:  Pharmaceutical Detail Drugs


SEC Filings Merrimack Pharmaceuticals

(9 days ago) SEC Filings Merrimack Pharmaceuticals. SEC Filings. Type. 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements. Filing year. - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003. - Any -.

Investors.merrimackpharma.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals: Recognizing Patterns of

(2 days ago) Client Profile & Challenge. Founded in 2000 with the mission of curing cancer, Merrimack Pharmaceuticals is a publicly-traded biopharmaceutical company known for innovative diagnostics and treatments. The company’s 350 employees have produced multiple cancer therapies now in clinical trials or in late-stage preclinical development.

Ccl.org

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals and similar companies

(1 days ago) Merrimack Pharmaceuticals is similar to these companies: Takeda Oncology, Vertex Pharmaceuticals, Catabasis Pharmaceuticals and more. Topic. Merrimack Pharmaceuticals. Share. Companies similar to or like Merrimack Pharmaceuticals. Pharmaceutical company based in …

Frankensaurus.com

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals, Inc. (A) - Case - Faculty

(3 days ago) Abstract. In 2006, Merrimack Pharmaceuticals was a fast-growing biotechnology company. Its leadership team was divided over whether to keep R&D organized in functional departments or transition to interdisciplinary teams. As a small company, Merrimack's R&D organization had established a culture of collaboration across scientific disciplines

Hbs.edu

Category:  Pharmaceutical Detail Drugs


Merrimack Pharmaceuticals (MACK) Recent Earnings

(8 days ago) Merrimack Pharmaceuticals (MACK) reported a Quarter June 2021 loss of $0.06 per share on revenue of $0.0 million.. Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.

Earningswhispers.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Merrimack Pharmaceuticals Potential Catalyst A Likely Bust

(7 days ago) Merrimack Pharmaceuticals (NASDAQ:MACK) is a small capitalization, clinical-stage pharmaceutical company focused on cancer therapies. Merrimack once was a commercial company, based on FDA approval

Seekingalpha.com

Category:  Pharmaceutical,  Cancer Detail Drugs


MACK Stock Forecast, Price & News (Merrimack Pharmaceuticals)

(6 days ago) Merrimack Pharmaceuticals' stock was trading at $2.76 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MACK shares have increased by 79.3% and is now trading at $4.95. View which stocks have been most impacted by COVID-19.

Marketbeat.com

Category:  Pharmaceutical,  Health Detail Drugs

Filter Type: